U.S. CDMO Capacity
More Than Capacity: What the Latest U.S. CDMO Expansion Wave Reveals About Specialized Manufacturing Demand
Pharma's Almanac
PAO-06-26-PA-18Jun 22, 2026
Expansion
Codis Unlocks Commercial-Scale Amorphous Solid Dispersions Manufacturing with GEA PSD4 Solvent Spray Dryer Investment
Codis
PR-02-26-08Mar 4, 2026
M&A
Fewer, Bigger, Smarter: How Pharma M&A Evolved in 2025 — and What Comes Next
David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-25-NI-07Dec 17, 2025
Market Trends
What economic or market trends are having the biggest impact on CDMO capacity and pipelines in 2025, and what will 2026 bring?
Pharma's Almanac
PAO-10-25-RT-01Nov 3, 2025
Injectables
Simtra BioPharma Solutions Announces Strategic Purchase to Expand U.S. Manufacturing Capacity for Injectable Medicines
Simtra BioPharma Solutions
PR-07-25-NI-3Jul 25, 2025
Multispecific Abs
Strategic Biomanufacturing Partner for Multispecific Antibodies
Youngsun Kim; Jina Kim; Busol Park
Samsung Biologics
PAO-04-25-CL-04Apr 14, 2025
Expansion
Vetter Boosts Pharmaceutical Storage Capacity with Major Warehouse Expansion
Vetter Pharma International GmbH
PR-03-25-NI-04Mar 11, 2025
Capacity Expansion
CiVentiChem Increases Capacity by 300% with New Facility; Celebrates 30th Anniversary
CiVentiChem
PR-08-24-NI-02Aug 13, 2024
Expansion
Vetter looks ahead to further expansions to meet supply chain demand
Vetter Pharma International GmbH
PR-M10-23-03Oct 17, 2023
CDMO Service and Capacity Expansion
Pharma Service Provider Further Expands Offerings for Clinical Development and Manufacturing
Vetter Pharma International GmbH
PR-M05-23-01May 9, 2023
New Biomanufacturing Facility
Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion
Samsung Biologics
PR-M03-23-05Mar 17, 2023
Biomanufacturing
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
Scorpius BioManufacturing
PAO-01-23-CL-04Jan 31, 2023
High Containment
Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India
Olon
PR-M09-22-06Sep 26, 2022
Manufacturing Investment
MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
MilliporeSigma
PR-M09-22-02Sep 8, 2022
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01Sep 7, 2022
Site Expansion
Vetter’s Newest Clinical Manufacturing Site Successfully Completed Its First Customer Fills
Vetter Pharma International GmbH
PR-M06-22-07Jun 28, 2022
Capacity Expansion
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business
Avid Bioservices
PR-M06-22-02Jun 13, 2022
New Facility
AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus
AGC Biologics
PR-M05-22-13-359May 18, 2022
Financial Results
Samsung Biologics Reports First Quarter 2022 Financial Results
Samsung Biologics
PR-M04-22-14Apr 27, 2022
Vaccine and Cell & Gene Therapies
Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics
Ulrike Fiedler Dr. Rer. Nat.
IDT Biologika
PAO-04-022-CL-02Apr 13, 2022